Semaglutide can lead to a higher risk of medullary thyroid cancer and biliary disease, a type of liver disease
Semaglutide and other GLP-1 receptor agonists have generated interest beyond diabetes management, with many patients asking whether these medications address underlying hormonal imbalances
Other therapeutic peptides like TB-500 and ipamorelin have also been subjects of interest
not guaranteed Regulatory status: Compounded GLP-1 medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing
If we think we can help you, well discuss exactly what we can do for you Fort Worth Law Office Locations & Hours Our main office in Fort Worth, TX, is located at 1310 W El Paso St, Fort Worth, TX 76102
When changing the plan is the right call Not every patient should stay on the same GLP-1 medication indefinitely